The Next Frontier in TAVR: Identifying Nonresponders and Treating Concomitant Pathologies
- PMID: 35393107
- DOI: 10.1016/j.jcin.2022.01.295
The Next Frontier in TAVR: Identifying Nonresponders and Treating Concomitant Pathologies
Keywords: aortic stenosis; functional status; transcatheter aortic valve replacement.
Conflict of interest statement
Funding Support and Author Disclosures Dr Wood is a consultant for and his institution receives grant support from Edwards Lifesciences, Abbott Vascular, and Medtronic. Dr Sathananthan is a consultant for and has received research funding from Edwards Lifesciences and Medtronic.
Comment on
-
Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial.JACC Cardiovasc Interv. 2022 Apr 11;15(7):728-738. doi: 10.1016/j.jcin.2022.01.284. JACC Cardiovasc Interv. 2022. PMID: 35393106
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources